Luke Pike

2.8k total citations
48 papers, 2.0k citations indexed

About

Luke Pike is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Luke Pike has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in Luke Pike's work include Brain Metastases and Treatment (20 papers), Lung Cancer Treatments and Mutations (12 papers) and Lung Cancer Research Studies (10 papers). Luke Pike is often cited by papers focused on Brain Metastases and Treatment (20 papers), Lung Cancer Treatments and Mutations (12 papers) and Lung Cancer Research Studies (10 papers). Luke Pike collaborates with scholars based in United States, United Kingdom and Canada. Luke Pike's co-authors include Adrian L. Harris, Tomasz Rzymski, Howard R. Mellor, Francesca M. Buffa, Brandon A. Mahal, Trevor J. Royce, William L. Hwang, Jay S. Loeffler, Jiannis Ragoussis and Ester M. Hammond and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer.

In The Last Decade

Luke Pike

43 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luke Pike United States 15 752 609 589 409 398 48 2.0k
Jonathan Fawcett Australia 25 682 0.9× 446 0.7× 527 0.9× 229 0.6× 375 0.9× 78 2.4k
Esther Bertrán Spain 24 1.5k 1.9× 284 0.5× 681 1.2× 232 0.6× 195 0.5× 43 2.3k
Douglas W. Strand United States 27 1.0k 1.3× 267 0.4× 529 0.9× 835 2.0× 159 0.4× 73 2.4k
Mitsuteru Natsuizaka Japan 25 839 1.1× 411 0.7× 659 1.1× 330 0.8× 100 0.3× 61 2.1k
Raleigh D. Kladney United States 23 996 1.3× 306 0.5× 505 0.9× 198 0.5× 258 0.6× 33 1.8k
G. Sliutz Austria 25 724 1.0× 387 0.6× 648 1.1× 185 0.5× 239 0.6× 73 1.9k
Mishie Tanino Japan 25 961 1.3× 263 0.4× 533 0.9× 650 1.6× 176 0.4× 117 2.3k
Kuang‐Den Chen Taiwan 20 860 1.1× 329 0.5× 190 0.3× 174 0.4× 576 1.4× 73 2.0k
Elias A. Castilla United States 19 768 1.0× 353 0.6× 306 0.5× 368 0.9× 133 0.3× 27 1.5k
Shuhei Yoshida Japan 16 563 0.7× 377 0.6× 264 0.4× 125 0.3× 294 0.7× 77 1.4k

Countries citing papers authored by Luke Pike

Since Specialization
Citations

This map shows the geographic impact of Luke Pike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Pike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Pike more than expected).

Fields of papers citing papers by Luke Pike

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke Pike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Pike. The network helps show where Luke Pike may publish in the future.

Co-authorship network of co-authors of Luke Pike

This figure shows the co-authorship network connecting the top 25 collaborators of Luke Pike. A scholar is included among the top collaborators of Luke Pike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke Pike. Luke Pike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pike, Luke, Helena A. Yu, & Chad G. Rusthoven. (2025). Management of EGFR-Variant and ALK-Positive Non–Small Cell Lung Cancer Brain Metastasis. JAMA Oncology. 11(6). 599–599.
2.
Tringale, Kathryn R., Anna Skakodub, Jacklynn V. Egger, et al.. (2024). Prognostic Implications of Small Cell Lung Cancer Transcriptional Subtyping for CNS Metastases. JCO Precision Oncology. 8(8). e2300470–e2300470. 2 indexed citations
3.
Hockemeyer, Kathryn, Chad G. Rusthoven, & Luke Pike. (2024). Advances in the Management of Lung Cancer Brain Metastases. Cancers. 16(22). 3780–3780. 2 indexed citations
4.
Gui, Chengcheng, Henry Walch, Ahmet Turan Ilıca, et al.. (2024). Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastases. Journal of neurosurgery. 142(2). 1–11.
5.
Balzo, Luke del, et al.. (2024). Artificial-intelligence-driven measurements of brain metastases’ response to SRS compare favorably with current manual standards of assessment. Neuro-Oncology Advances. 6(1). vdae015–vdae015. 5 indexed citations
6.
Perlow, Haley K., David R. Raleigh, Tony J. C. Wang, et al.. (2024). Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected Meningiomas. International Journal of Radiation Oncology*Biology*Physics. 122(1). 150–158. 2 indexed citations
7.
Skakodub, Anna, Henry Walch, Kathryn R. Tringale, et al.. (2023). Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis. Nature Communications. 14(1). 4980–4980. 28 indexed citations
8.
Lebow, Emily S., Luke Pike, Andrew D. Seidman, et al.. (2023). Symptomatic Necrosis With Antibody-Drug Conjugates and Concurrent Stereotactic Radiotherapy for Brain Metastases. JAMA Oncology. 9(12). 1729–1729. 28 indexed citations
9.
Imber, Brandon S., Anne S. Reiner, Ahmet Turan Ilıca, et al.. (2023). Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC. JTO Clinical and Research Reports. 4(12). 100607–100607. 4 indexed citations
10.
Bander, Evan D., Tarek Y. El Ahmadieh, Justin Chen, et al.. (2023). Outcomes Following Early Postoperative Adjuvant Radiosurgery for Brain Metastases. JAMA Network Open. 6(10). e2340654–e2340654. 5 indexed citations
11.
Wijetunga, N. Ari, et al.. (2022). Recent Advances and Applications of Radiation Therapy for Brain Metastases. Current Oncology Reports. 24(3). 335–342. 9 indexed citations
12.
Skakodub, Anna, Kathryn R. Tringale, Henry Walch, et al.. (2022). Genomic analysis and clinical correlations of non-small cell lung cancer (NSCLC) brain metastasis (BM).. Journal of Clinical Oncology. 40(16_suppl). 2008–2008. 4 indexed citations
13.
Butler, Santino, Idalid Franco, Vinayak Muralidhar, et al.. (2019). Conservative management of low‐risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database. Cancer. 125(19). 3338–3346. 13 indexed citations
14.
Pike, Luke, Andrew Bang, Mai Anh Huynh, et al.. (2019). Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated With Anti-PD-1 Therapy. Frontiers in Oncology. 9. 199–199. 11 indexed citations
15.
Hwang, William L., Luke Pike, Trevor J. Royce, Brandon A. Mahal, & Jay S. Loeffler. (2018). Safety of combining radiotherapy with immune-checkpoint inhibition. Nature Reviews Clinical Oncology. 15(8). 477–494. 230 indexed citations
16.
Pike, Luke, Kanchan Phadwal, Anna Katharina Simon, & Adrian L. Harris. (2012). ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia. Molecular Biology Reports. 39(12). 10811–10822. 27 indexed citations
17.
Rzymski, Tomasz, Andreas Petry, Damir Kračun, et al.. (2011). The unfolded protein response controls induction and activation of ADAM17/TACE by severe hypoxia and ER stress. Oncogene. 31(31). 3621–3634. 63 indexed citations
18.
Yang, Jun, Adrian M. Jubb, Luke Pike, et al.. (2010). The Histone Demethylase JMJD2B Is Regulated by Estrogen Receptor α and Hypoxia, and Is a Key Mediator of Estrogen Induced Growth. Cancer Research. 70(16). 6456–6466. 143 indexed citations
19.
Milani, Manuela, Tomasz Rzymski, Howard R. Mellor, et al.. (2009). The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib. Cancer Research. 69(10). 4415–4423. 255 indexed citations
20.
Radcliffe, John D., Pat Ansell, Diana Bull, et al.. (1992). Cryptorchidism: a prospective study of 7500 consecutive male births, 1984-8. John Radcliffe Hospital Cryptorchidism Study Group.. Archives of Disease in Childhood. 67(7). 892–899. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan Fawcett Breakdown of academic impact, for papers by Esther Bertrán Breakdown of academic impact, for papers by Douglas W. Strand Breakdown of academic impact, for papers by Mitsuteru Natsuizaka Breakdown of academic impact, for papers by Raleigh D. Kladney Breakdown of academic impact, for papers by G. Sliutz Breakdown of academic impact, for papers by Mishie Tanino Breakdown of academic impact, for papers by Kuang‐Den Chen Breakdown of academic impact, for papers by Elias A. Castilla Breakdown of academic impact, for papers by Shuhei Yoshida
Rankless by CCL
2026